Clinical Trials in Manila, National Capital Region
9 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)
Healthy
Merck Sharp & Dohme LLC12,000 enrolled39 locationsNCT07013487
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC556 enrolled194 locationsNCT06074588
Recruiting
Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled222 locationsNCT06667700
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled78 locationsNCT07044297
Recruiting
Phase 2
Preventive Strategies for Early and Late Complications of Leptospirosis
Leptospirosis
National Kidney and Transplant Institute, Philippines678 enrolled3 locationsNCT07127718
Recruiting
Phase 3
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Chikungunya Virus
Bavarian Nordic720 enrolled15 locationsNCT07003984
Recruiting
Phase 3
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women
Influenza
Sinovac Biotech Co., Ltd150 enrolled2 locationsNCT07211152
Recruiting
Monitoring Drug Efficacy in Patients with Alzheimer's Disease
Alzheimer Disease
University of the Philippines60 enrolled1 locationNCT05801380